Novavax Inc
LSE:0A3S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novavax Inc
LSE:0A3S
|
US |
|
A
|
Alnylam Pharmaceuticals Inc
XMUN:DUL
|
US |
|
Agree Realty Corp
NYSE:ADC
|
US |
|
Avantor Inc
NYSE:AVTR
|
US |
|
H
|
Halma PLC
DUS:H11
|
UK |
|
Kadokawa Corp
TSE:9468
|
JP |
|
E
|
E ON SE
PSE:EOAN
|
DE |
|
JB Hi-Fi Ltd
ASX:JBH
|
AU |
|
NetApp Inc
NASDAQ:NTAP
|
US |
|
N
|
National Australia Bank Ltd
DUS:NAL
|
AU |
|
A
|
Atlantia SpA
XHAM:AU9
|
IT |
|
T
|
Target Corp
XBER:DYH
|
US |
|
D
|
DBV Technologies SA
XMUN:DBV
|
FR |
|
B
|
Brookfield Asset Management Inc
TSX:BAM.A
|
CA |
|
L
|
Lenovo Group Ltd
DUS:LHL
|
CN |
|
S
|
Scandinavian Medical Solutions A/S
F:K41
|
DK |
|
N
|
Natural Gas Services Group Inc
XBER:NGS
|
US |
|
V
|
Volkswagen AG
OTC:VWAGY
|
DE |
|
V
|
VICI Properties Inc
F:1KN
|
US |
|
Prudential Financial Inc
NYSE:PRU
|
US |
|
Lemonade Inc
LSE:0A91
|
US |
|
C
|
Credit Suisse Group AG
F:CSX
|
CH |
|
S
|
Spirit AeroSystems Holdings Inc
F:S9Q
|
US |
Wall St Price Targets
0A3S Price Targets Summary
Novavax Inc
According to Wall Street analysts, the average 1-year price target for 0A3S is 13.9166 USD with a low forecast of 6.8359 USD and a high forecast of 25.3806 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A3S's stock price target?
Price Target
13.9166
USD
According to Wall Street analysts, the average 1-year price target for 0A3S is 13.9166 USD with a low forecast of 6.8359 USD and a high forecast of 25.3806 USD.
What is the Revenue forecast for Novavax Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 0%.
What is the Gross Profit forecast for Novavax Inc?
Projected CAGR
-31%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 46%. The projected CAGR for the next 3 years is -31%.
What is the Operating Income forecast for Novavax Inc?
Projected CAGR
2%
The compound annual growth rate for Operating Income over the next 8 years is 2%.
What is the Pre-Tax Income forecast for Novavax Inc?
Projected CAGR
-41%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -41%.
What is the Net Income forecast for Novavax Inc?
Projected CAGR
-21%
The compound annual growth rate for Net Income over the next 7 years is -21%.
